Latest stories on FLNA
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
GlobeNewswire58 · neutralproduct/pr
Filana Therapeutics Announces Publication in Cells of Promising Preclinical Findings for Simufilam in TSC2-Deficient Cells
StockTitan58 · neutralproduct/pr
FILANA THERAPEUTICS, INC. (FLNA) files 8-K
SEC 8-K50 · neutralgeneral
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
GlobeNewswire52 · neutralproduct/pr
Filana Therapeutics to Participate in the 2026 Maxim Growth Summit
Business Insider52 · neutralproduct/pr
FLNA jumps after FDA lifts clinical hold, clearing a 40-patient Phase 2a path for simufilam in TSC-related epilepsy
September 22, 2026
MarketChameleon67 · bullishproduct/pr
Filana Therapeutics announces U.S. FDA lifted clinical hold on simufilam
The Fly62 · neutralproduct/pr
FILANA THERAPEUTICS, INC. (FLNA) files 8-K
SEC 8-K50 · neutralgeneral
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
StockTitan67 · bullishproduct/pr
Filana Therapeutics Announces FDA Lift of Clinical Hold on Simufilam, Enabling Phase 2a Study in TSC-Related Epilepsy
GlobeNewswire67 · bullishproduct/pr
Filana Therapeutics Receives Nasdaq Minimum Bid Price Notice
TipRanks34 · bearishgeneral
FILANA THERAPEUTICS, INC. (FLNA) files 8-K
SEC 8-K34 · bearishgeneral
FILANA THERAPEUTICS, INC. (FLNA) files 8-K
SEC 8-K50 · neutralgeneral
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
StockTitan50 · neutralgeneral
FILANA THERAPEUTICS, INC. (FLNA) files 8-K
SEC 8-K50 · neutralgeneral